Stay updated on DoceRamPem in NSCLC Clinical Trial
Sign up to get notified when there's something new on the DoceRamPem in NSCLC Clinical Trial page.

Latest updates to the DoceRamPem in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page has updated the date for the Phase 2 DoceRamPem trial for patients with metastatic or recurrent NSCLC from February 13, 2024, to February 26, 2025.SummaryDifference1.0%
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check42 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
Stay in the know with updates to DoceRamPem in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DoceRamPem in NSCLC Clinical Trial page.